Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 64Active not recruiting 47Completed 14Terminated 7Not yet recruiting 7Withdrawn 2Suspended 2Enrolling by invitation 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1Genitourinary 1Dermatologic 1

Conditions

Neoplasms 1Melanoma 1Carcinoma, Renal Cell 1

Interventions

Specimen Handling 31Magnetic Resonance Spectroscopy 19Biopsy 16Cyclophosphamide 10venetoclax 7Nivolumab 6Azacitidine 6pembrolizumab 5Vincristine 5Etoposide 5fludarabine phosphate 4Surgical Procedures, Operative 4Radiotherapy, Intensity-Modulated 4Radiation 4Injections 4Doxorubicin 4Cisplatin 4fludarabine 3X-Rays 3Taxes 3Tacrolimus 3Surveys and Questionnaires 3Radiosurgery 3Prednisone 3Leucovorin 3Irinotecan 3Ipilimumab 3Fluorouracil 3Educational Status 3Dexamethasone 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Suspended × Practice Guidelines as Topic × 1 year × Clear all
NCT06391099 2026-05-26

Ketogenic Dietary Intervention to Improve Response to Immunotherapy in Patients With Metastatic Melanoma and Metastatic Kidney Cancer

Ohio State University Comprehensive Cancer Center

Phase NA Suspended
60 enrolled
DermatologicGenitourinary

Carcinoma, Renal Cell, Melanoma

NCT03568292 2026-05-13

Virtual Reality in Reducing Pain and Anxiety in Cancer Participants Undergoing Painful Procedures

University of Southern California

Phase NA Suspended
60 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡